R.H. Bluestein & Co’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $419K | Hold |
40,000
| – | – | 0.03% | 168 |
|
|
2022
Q2 | $443K | Hold |
40,000
| – | – | 0.03% | 179 |
|
|
2022
Q1 | $446K | Hold |
40,000
| – | – | 0.02% | 213 |
|
|
2021
Q4 | $523K | Sell |
40,000
-10,000
| -20% | -$126K | 0.02% | 209 |
|
|
2021
Q3 | $651K | Buy |
50,000
+10,000
| +25% | +$133K | 0.03% | 178 |
|
|
2021
Q2 | $588K | Hold |
40,000
| – | – | 0.02% | 205 |
|
|
2021
Q1 | $491K | Hold |
40,000
| – | – | 0.02% | 219 |
|
|
2020
Q4 | $570K | Hold |
40,000
| – | – | 0.03% | 172 |
|
|
2020
Q3 | $556K | Hold |
40,000
| – | – | 0.03% | 148 |
|
|
2020
Q2 | $424K | Hold |
40,000
| – | – | 0.02% | 168 |
|
|
2020
Q1 | $323K | Hold |
40,000
| – | – | 0.03% | 167 |
|
|
2019
Q4 | $325K | Hold |
40,000
| – | – | 0.02% | 260 |
|
|
2019
Q3 | $303K | Hold |
40,000
| – | – | 0.02% | 243 |
|
|
2019
Q2 | $300K | Hold |
40,000
| – | – | 0.02% | 240 |
|
|
2019
Q1 | $324K | Hold |
40,000
| – | – | 0.02% | 205 |
|
|
2018
Q4 | $302K | Hold |
40,000
| – | – | 0.02% | 182 |
|
|
2018
Q3 | $277K | Hold |
40,000
| – | – | 0.01% | 266 |
|
|
2018
Q2 | $258K | Sell |
40,000
-35,000
| -47% | -$221K | 0.01% | 269 |
|
|
2018
Q1 | $490K | Hold |
75,000
| – | – | 0.03% | 160 |
|
|
2017
Q4 | $563K | Hold |
75,000
| – | – | 0.03% | 136 |
|
|
2017
Q3 | $535K | Sell |
75,000
-25,000
| -25% | -$180K | 0.03% | 148 |
|
|
2017
Q2 | $843K | Hold |
100,000
| – | – | 0.05% | 87 |
|
|
2017
Q1 | $803K | Hold |
100,000
| – | – | 0.05% | 97 |
|
|
2016
Q4 | $906K | Hold |
100,000
| – | – | 0.06% | 73 |
|
|
2016
Q3 | $928K | Hold |
100,000
| – | – | 0.06% | 68 |
|
|
2016
Q2 | $1.02M | Sell |
100,000
-10,000
| -9% | -$91.7K | 0.08% | 55 |
|
|
2016
Q1 | $994K | Sell |
110,000
-20,000
| -15% | -$179K | 0.07% | 73 |
|
|
2015
Q4 | $1.2M | Hold |
130,000
| – | – | 0.08% | 68 |
|
|
2015
Q3 | $1.66M | Hold |
130,000
| – | – | 0.12% | 55 |
|
|
2015
Q2 | $1.44M | Sell |
130,000
-5,000
| -4% | -$55.2K | 0.09% | 70 |
|
|
2015
Q1 | $1.54M | Hold |
135,000
| – | – | 0.09% | 69 |
|
|
2014
Q4 | $1.36M | Buy |
135,000
+25,000
| +23% | +$263K | 0.09% | 83 |
|
|
2014
Q3 | $1.16M | Sell |
110,000
-25,000
| -19% | -$235K | 0.07% | 96 |
|
|
2014
Q2 | $1.17M | Hold |
135,000
| – | – | 0.07% | 102 |
|
|
2014
Q1 | $1.19M | Hold |
135,000
| – | – | 0.08% | 100 |
|
|
2013
Q4 | $1.11M | Sell |
135,000
-2,500
| -2% | -$19.8K | 0.07% | 102 |
|
|
2013
Q3 | $1.04M | Hold |
137,500
| – | – | 0.07% | 106 |
|
|
2013
Q2 | $1.04M | Buy |
+137,500
| New | +$1M | 0.09% | 99 |
|
Other funds holding RDY
R.H. Bluestein & Co's RDY Position: Q3 2022 in Review
R.H. Bluestein & Co held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2022 at 40,000 shares worth $419K. The position accounts for 0.03% of the portfolio, ranked #168.
R.H. Bluestein & Co first reported a position in RDY in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.66M in Q3 2015. 151 funds tracked by Wall St. Rank hold RDY as of Q3 2022.
- R.H. Bluestein & Co held 40,000 shares of Dr. Reddy's Laboratories worth $419K as of Q3 2022.
- R.H. Bluestein & Co left its Dr. Reddy's Laboratories share count unchanged in Q3 2022.
- Dr. Reddy's Laboratories made up 0.03% of R.H. Bluestein & Co's portfolio in Q3 2022, its #168 holding.
- R.H. Bluestein & Co first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 38 quarters since.
- R.H. Bluestein & Co's Dr. Reddy's Laboratories position peaked at $1.66M in Q3 2015.
- 151 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2022.
Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.